about
Dysfunction of respiratory muscles in critically ill patients on the intensive care unitIdentification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.2-year survival of patients undergoing mild hypothermia treatment after ventricular fibrillation cardiac arrest is significantly improved compared to historical controls.The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial.Mitochondrial function of immune cells in septic shock: A prospective observational cohort study.Mild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation: 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients.High-mobility group box-1 protein serum levels do not reflect monocytic function in patients with sepsis-induced immunosuppression.Strong association of phenylalanine and tryptophan metabolites with activated cytomegalovirus infection in kidney transplant recipients.Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis.Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shockPrehospital cooling with hypothermia caps (PreCoCa): a feasibility study.Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life.Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report.Prehospital therapeutic hypothermia in cardiac arrest: will there ever be evidence?Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls.Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trialNon-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study.Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure.Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysisManagement of severe abdominal infections.Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study.Organ crosstalk in critically ill patients: hemofiltration and immunomodulation in sepsis.Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders.Mycoplasma-induced minimally conscious state.Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.Teaching End-of-Life Communication in Intensive Care Medicine: Review of the Existing Literature and Implications for Future Curricula.Stress ulcer prophylaxis in the intensive care unit trial: detailed statistical analysis plan.Heart failure and kidney dysfunction: epidemiology, mechanisms and management.Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia.Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shockInfluence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest.Hypertonic saline in critical illness - A systematic review.Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.Sepsis: time has come to focus on the later stages.Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: a prospective observational analysis.Effects of dialysis modality on blood loss, bleeding complications and transfusion requirements in critically ill patients with dialysis-dependent acute renal failure.Inconsistent effects of acidosis on HIF-alpha protein and its target genes.Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure - Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
P50
Q26749263-A6A3C87A-55D4-4BAA-B26D-44835CBE39A6Q28743491-83DC567B-35F5-432D-802A-C6F19E9E82F2Q33488545-A8711334-B2F9-4623-89E5-A4D348DB9440Q33638663-3D820F76-DA37-40B6-85A3-5B7AC753E0DBQ33750046-FDBF0867-98D8-4CAC-AA09-0650CD6D8124Q33773086-C67540A4-7355-4AA0-B14B-9561B33012CCQ33919289-3CE5E5F9-2422-4383-909D-EDEB887FF1EAQ34003036-012C5D83-9ED8-4F55-87B7-A684946F0B77Q34091934-52ECC76F-954E-49F7-8626-54DF92B03943Q34345561-188ECFE3-46AF-47D4-A0CA-0B6C34A4BF08Q34436992-9B111EC1-186D-4B83-9C04-BD223A100B7EQ34697264-AAA27DF6-9D97-4304-A37B-4D2E5FC672D4Q34782808-9AA58642-A07B-41AF-8927-2B708820F319Q36084695-1D25FAF4-D207-4F27-8132-41AA98B84441Q36405066-10F24D02-067D-4169-9F55-F4A6CE414D1BQ36749006-540B4257-80E7-4B8F-9386-2EB4F2C06C5AQ36787279-43A95C0B-4474-4B9F-85F7-F2DFD1659DEFQ36815246-AB685C0B-8226-448E-89A0-03A7E8832974Q36829069-48A67075-480E-4ACA-B1FF-8005788477A6Q37320333-9683DA73-96B7-432D-955F-36F8799AE510Q37360321-F2933AA3-DC3C-44B8-862F-AE32EE39FF81Q37370667-D0BFF7D6-73F4-42DC-A441-E444798C637CQ37443202-2A5CF53D-E1E0-436A-B6D9-90D2473E9E17Q37511521-5C0793F2-5CB1-4684-AF8F-43A0C804471FQ37561789-558F27E5-6B69-4224-B7A7-A0DC3E02B114Q38605046-AC806605-8E48-4F05-9F90-BE759655330CQ38609743-A6693B90-1075-48C6-A06E-2676D0E8E3F1Q38665499-4E4EAB95-1725-4729-BADD-DD12164302C7Q38728261-21BD8913-28E1-4DD3-B9FA-A47268450035Q38826590-0D874630-468C-41FA-A0EC-A2EA0FF9E7FAQ38898084-66BEA0BC-A028-40B3-AB0D-3D4550116A4CQ39200407-1FABDB28-2DA1-4BD1-BA83-C2DCF7228EA9Q39449533-F013B242-15A9-4454-B37B-9866B89BE26AQ39459655-57413039-9330-4630-A9AE-CDF4B313D207Q39907258-BB6109DE-A5D8-4612-ABBD-44190CAA927BQ40096916-2ED49F74-58D4-4D23-8C93-18ABC71FCE87Q40181831-A0B09793-DA8C-454B-A251-42A2055EE11DQ40278651-29BE800B-205B-4A67-9EC7-3AB22E9D775DQ40364979-0B4BD30B-7F50-41D2-AD92-1D9C3DD42A44Q40448001-1230CEDB-9ACC-4B87-8438-7F64A266D135
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joerg C Schefold
@ast
Joerg C Schefold
@en
Joerg C Schefold
@es
Joerg C Schefold
@nl
type
label
Joerg C Schefold
@ast
Joerg C Schefold
@en
Joerg C Schefold
@es
Joerg C Schefold
@nl
prefLabel
Joerg C Schefold
@ast
Joerg C Schefold
@en
Joerg C Schefold
@es
Joerg C Schefold
@nl
P214
P106
P108
P214
P31
P496
0000-0001-9162-5724
P734
P7859
viaf-10923762